Purchase Order N3239823P0304
Award Date 1/6/23
Potential Completion Date 1/12/24
Potential Value $126K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of biotechnology and genomic analysis products, for the delivery of one NovaSeq 6000 sequencing system. The $945,107.50 contract will support COVID-19 research at the Naval Medical Research Center in Fort Detrick, Maryland. The contract includes installation and training services. This requirement was a brand name-only solicitation with...
- This is a firm fixed-price purchase order awarded by the Uniformed Services University of the Health Sciences, a Defense agency, to Illumina, Inc. for the provision of a NovaSeq X Plus Sequencing System. The $1,083,750.00 contract does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of providing sequencing systems, reagents, and related services to support research and...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...
- This is a $111,420.00 firm fixed price purchase order awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc. for a "SILVER SUPPORT PLAN" contract. The contract has a completion date of September 25, 2022 and does not utilize a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. Through past prime federal contract awards, Illumina has provided a range of goods and...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
- This is a $249,998.65 firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The order is for NovaSeq X Series sequencing reagent kits and freight, with a period of performance through September 2025. This order is part of a broader indefinite delivery contract Illumina holds with the Department of the...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
- This is a $752,450 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract...
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...